Trial intelligence / Profile preview

Methylphenidate effects on alpha oscillation modulation in children with ADHD

NL-OMON27284Active, not recruiting

Sponsor
Radboud University
Start
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Radboud University. Primary endpoints: Alpha Lateralization Index, Alpha Modulation Index and 4 more. Started Oct 2016; status: active, not recruiting.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NL-OMON27284.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON27284.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call